BHVN Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

03

Fiyat $12.82

Piyasa Değeri (MRQ) $1.94B

P/E -1.9

Hisse Başına Kâr $-6.86

ROE -310.8%

52 Haftlık Aralık $7–$19

BHVN Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

04

aralık

çubuklar

Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

06

Hisse Başına Kâr$-6.86

2020-12-31 → 2025-12-31

Serbest Nakit Akışı$-610M

2022-12-31 → 2025-12-31

Değerleme ve Oranlar 07–12

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik	BHVN	5Y ort.	Akran Ortalaması	Sonuç
P/E	-1.95Y ort. ≈-3.6	≈-3.6	·	·
F/D (MRQ)	158.45Y ort. ≈11.9	≈11.9	4.3	Aşırı değerli
Fiyat / Serbest Nakit Akışı (TTM)	-3.85Y ort. ≈-5.6	≈-5.6	·	·
Fiyat / Nakit Akışı (TTM)	-3.85Y ort. ≈-5.6	≈-5.6	·	·
Fiyat / Maddi Defter Değeri (MRQ)	-313.45Y ort. ≈16.5	≈16.5	·	·

Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik	BHVN	5Y ort.	Akran Ortalaması	Sonuç
ROA	-138.5%5Y ort. ≈-125.0%	≈-125.0%	-36.1%	Zayıf
ROE	-310.8%5Y ort. ≈-199.1%	≈-199.1%	-60.0%	Zayıf
ROIC	-1434.2%5Y ort. ≈-462.6%	≈-462.6%	-62.7%	Zayıf

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik	5 Yıllık trend	BHVN	5Y ort.	Akran Ortalaması	Sonuç
Cari Oran (MRQ)		4.75Y ort. ≈5.3	≈5.3	5.5	Düşük likidite
Quick Ratio (Cari Oran)		2.85Y ort. ≈4.5	≈4.5	4.5	Düşük likidite

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik	BHVN	5Y ort.	Akran Ortalaması	Sonuç
EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))	$-6.865Y ort. ≈$-8.01	≈$-8.01	·	·
Cash Flow / Share (Hisse Başına Nakit Akışı)	$-5.665Y ort. ≈$-5.84	≈$-5.84	·	·
Cash / Share (Hisse Başına Nakit)	$1.735Y ort. ≈$2.19	≈$2.19	·	·

değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

14

Ort. Sürpriz -4.8%

Sonraki Rapor Kas 09, 2026

Dönem	Rapor	EPS Gerçek	EPS Tahmin	Sürpriz
30 Haziran 2026	Ağu 10, 2026	$-0.91	$-0.75	-21.7%
31 Mart 2026		$-0.88	$-0.84	-4.2%
31 Aralık 2025		$-1.21	$-1.32	8.0%
30 Eylül 2025		$-1.64	$-1.93	15.0%
30 Haziran 2025		$-1.94	$-1.93	-0.55%
31 Mart 2025		$-2.17	$-1.73	-25.5%

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

15

Gelir Tablosu 13

Metrik	2025	2024	2023	2022	2021
R&D Expense	$635M	$796M	$373M	$437M	$181M
SG&A Expense	$110M	$89M	$63M	$131M	$37M
Operating Expenses	$745M	$885M	$436M	$568M	$219M
Operating Income	$-745M	$-885M	$-436M	$-568M	$-219M
Other Non-op	$8M	$39M	$26M	$-2M	$1M
Pretax Income	$-737M	$-846M	$-410M	$-570M	$-212M
Income Tax	$1M	$735.0K	$-1M	$438.0K	$1M
Net Income	$-739M	$-846M	$-408M	$-570M	$-214M
EPS (Basic)	$-6.86	$-9.28	$-5.73	$-12.75	$-5.43
EPS (Diluted)	$-6.86	$-9.28	$-5.73	$-12.75	$-5.43
Shares (Basic)	107,624,885	91,234,337	71,200,527	44,741,316	39,375,944
Shares (Diluted)	107,624,885	91,234,337	71,200,527	44,741,316	39,375,944
EBITDA	$-735M	$-877M	$-429M	$-567M	·

Bilanço 24

Metrik	2025	2024	2023	2022	2021
Cash & Equivalents	$230M	$99M	$248M	$205M	$76M
Short-term Investments	$89M	$387M	$133M	$260M	$0
Prepaid Expense	$47M	$49M	$35M	$21M	$7M
Other Current Assets	$2M	$3M	$12M	$19M	$2M
Current Assets	$368M	$538M	$442M	$587M	$95M
PP&E (Net)	$16M	$17M	$17M	$18M	$13M
Accum. Depreciation	$16M	$12M	$8M	$5M	$3M
Goodwill	$1M	$1M	$1M	$1M	$1M
Intangibles	$18M	$18M	$18M	$18M	$18M
Other Non-current Assets	$47M	$40M	$34M	$38M	$14M
Total Assets	$451M	$615M	$513M	$662M	$142M
Accounts Payable	$12M	$18M	$16M	$11M	$5M
Accrued Liabilities	$104M	$51M	$40M	$44M	$37M
Current Liabilities	$116M	$154M	$55M	$90M	$42M
Capital Leases	$40M	$33M	$28M	$31M	$3M
Other Non-current Liabilities	$5M	$5M	$2M	$2M	$3M
Total Liabilities	$399M	$192M	$85M	$123M	$47M
Common Stock	$1.93B	$1.66B	$888M	$616M	$0
Paid-in Capital	$194M	$112M	$40M	$14M	$0
Retained Earnings	$-2.08B	$-1.35B	$-499M	$-91M	$0
AOCI	$8M	$79.0K	$-65.0K	$284.0K	$0
Stockholders' Equity	$52M	$423M	$428M	$539M	$35M
Liabilities + Equity	$451M	$615M	$513M	$662M	$142M
Shares Outstanding	132,775,113	101,221,989	81,115,723	68,190,479	0

Nakit Akışı 13

Metrik	2025	2024	2023	2022	2021
D&A	$10M	$8M	$7M	$1M	$1M
Stock-based Comp	$112M	$72M	$29M	$194M	$66M
Deferred Tax	$0	$0	$0	$0	$0
Other Non-cash	$7M	$184M	$41M	$78M	·
Operating Cash Flow	$-609M	$-582M	$-332M	$-298M	$-146M
CapEx	$715.0K	$4M	$3M	$6M	$938.0K
Investing Cash Flow	$301M	$-245M	$130M	$-305M	$944.0K
Stock Issued	$189M	$666M	$243M	$284M	$0
Net Stock Activity	$189M	$666M	$243M	$284M	·
Financing Cash Flow	$439M	$678M	$212M	$768M	$138M
Net Change in Cash	$130M	$-150M	$10M	$166M	$-6M
Taxes Paid	$133.0K	$-10M	$-33M	$38M	$17M
Free Cash Flow	$-610M	$-587M	$-335M	$-304M	·

Kârlılık 3

Metrik	2025	2024	2023	2022	2021
ROA	-138.5%	-150.0%	-69.5%	-141.9%	·
ROE	-310.8%	-198.8%	-84.4%	-202.3%	·
ROIC	-1434.2%	-209.2%	-101.5%	-105.5%	·

Likidite ve Solventlik 2

Metrik	Eğilim	2025	2024	2023	2022	2021
Current Ratio		3.2	3.5	8.0	6.5	·
Quick Ratio		2.8	3.2	6.9	5.2	·

Hisse Başına 4

Metrik	2025	2024	2023	2022	2021
Book Value / Share	$0.39	$4.18	$5.28	$7.90	·
Cash Flow / Share	$-5.66	$-6.38	$-4.66	$-6.65	·
Cash / Share	$1.73	$0.98	$3.06	$3.00	·
EPS (TTM)	$-6.86	$-9.28	$-5.73	$-12.75	·

Değerleme (TTM) 8

Metrik	2025	2024	2023	2022	2021
Net Income TTM	$-739M	$-846M	$-408M	$-570M	·
Market Cap	$1.50B	$3.78B	$3.47B	$946M	·
P/E	-1.6	-4.0	-7.5	-1.1	·
P/B	28.8	8.9	8.1	1.8	·
P / Tangible Book	46.4	9.4	8.5	1.8	·
P / Cash Flow	-2.5	-6.5	-10.5	-3.2	·
P / FCF	-2.5	-6.4	-10.4	-3.1	·
Earnings Yield	-60.8%	-24.9%	-13.4%	-91.9%	·

Gelir Tablosu 13

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
R&D Expense	$101M	$104M	$122M	$141M	$184M	$188M	$167M	$158M	$315M	$156M	$135M	$96M	$79M	$63M	$53M	$177M
SG&A Expense	$24M	$27M	$21M	$28M	$27M	$34M	$22M	$21M	$19M	$27M	$19M	$15M	$15M	$14M	$15M	$20M
Operating Expenses	$125M	$130M	$143M	$169M	$212M	$222M	$190M	$178M	$334M	$183M	$154M	$111M	$94M	$78M	$68M	$197M
Operating Income	$-125M	$-130M	$-143M	$-169M	$-212M	$-222M	$-190M	$-178M	$-334M	$-183M	$-154M	$-111M	$-94M	$-78M	$-68M	$-197M
Other Non-op	$-12M	$168.0K	$-2M	$-4M	$14M	$493.0K	$3M	$18M	$14M	$4M	$8M	$5M	$6M	$8M	$0	$-67.0K
Pretax Income	$-137M	$-130M	$-145M	$-173M	$-198M	$-221M	$-187M	$-160M	$-320M	$-179M	$-146M	$-106M	$-88M	$-70M	$-68M	$-197M
Income Tax	$391.0K	$272.0K	$351.0K	$221.0K	$261.0K	$609.0K	$48.0K	$-59.0K	$177.0K	$569.0K	$-1M	$-3M	$2M	$939.0K	$1M	$6M
Net Income	$-137M	$-131M	$-146M	$-173M	$-198M	$-222M	$-187M	$-160M	$-320M	$-180M	$-145M	$-103M	$-90M	$-70M	$-69M	$-203M
EPS (Basic)	$-0.91	$-0.88	$-1.11	$-1.64	$-1.94	$-2.17	$-1.74	$-1.70	$-3.64	$-2.20	$-1.88	$-1.50	$-1.32	$-1.03	$-1.75	$-5.16
EPS (Diluted)	$-0.91	$-0.88	$-1.11	$-1.64	$-1.94	$-2.17	$-1.74	$-1.70	$-3.64	$-2.20	$-1.88	$-1.50	$-1.32	$-1.03	$-1.75	$-5.16
Shares (Basic)	150,636,620	147,615,197	·	105,815,038	102,372,820	101,943,396	·	94,372,159	87,766,069	81,601,826	·	68,320,125	68,248,023	68,206,879	39,375,944	39,375,944
Shares (Diluted)	150,636,620	147,615,197	·	105,815,038	102,372,820	101,943,396	·	94,372,159	87,766,069	81,601,826	·	68,320,125	68,248,023	68,206,879	39,375,944	39,375,944
EBITDA	$-125M	$-128M	·	$-169M	$-212M	$-219M	·	$-178M	$-334M	$-182M	·	$-111M	$-94M	$-76M	$-68M	·

Bilanço 24

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Cash & Equivalents	$238M	$273M	$230M	$185M	$166M	$98M	$99M	$84M	$239M	$183M	$248M	$112M	$148M	$125M	$51M	·
Short-term Investments	$30M	$75M	$89M	$75M	$239M	$224M	$387M	$294M	$198M	$101M	·	$129M	$188M	$263M	·	·
Prepaid Expense	$27M	$35M	$47M	$55M	$61M	$56M	$49M	$55M	$60M	$46M	·	$34M	$28M	$26M	$18M	·
Other Current Assets	$2M	$3M	$2M	$8M	$8M	$4M	$3M	$1M	$7M	$11M	·	$23M	$22M	$25M	$12M	·
Current Assets	$297M	$386M	$368M	$324M	$475M	$383M	$538M	$440M	$511M	$349M	·	$311M	$434M	$544M	$81M	·
PP&E (Net)	$15M	$15M	$16M	$18M	$19M	$18M	$17M	$18M	$19M	$17M	·	$18M	$17M	$17M	$17M	·
Accum. Depreciation	$17M	$17M	$16M	$15M	$14M	$13M	$12M	$11M	$10M	$9M	·	$7M	$6M	$6M	$5M	·
Goodwill	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	·	$1M	$1M	$1M	$1M	·
Intangibles	$18M	$18M	$18M	$18M	$18M	$18M	$18M	$18M	$18M	$18M	·	$18M	$18M	$18M	$18M	·
Other Non-current Assets	$39M	$46M	$47M	$48M	$37M	$39M	$40M	$32M	$33M	$33M	·	$35M	$36M	$37M	$18M	·
Total Assets	$371M	$466M	$451M	$409M	$550M	$459M	$615M	$511M	$583M	$419M	·	$383M	$507M	$619M	$136M	·
Accounts Payable	$12M	$10M	$12M	$17M	$20M	$19M	$18M	$20M	$17M	$36M	·	$10M	$12M	$14M	$5M	·
Accrued Liabilities	$51M	$42M	$104M	$74M	$79M	$57M	$51M	$64M	$58M	$50M	·	$53M	$35M	$38M	$24M	·
Current Liabilities	$63M	$52M	$116M	$113M	$124M	$164M	$154M	$152M	$156M	$87M	·	$62M	$88M	$114M	$28M	·
Capital Leases	$33M	$38M	$40M	$40M	$30M	$31M	$33M	$25M	$26M	$27M	·	$28M	$29M	$30M	$4M	·
Other Non-current Liabilities	$3M	$5M	$5M	$5M	$5M	$5M	$5M	$5M	$4M	$3M	·	$2M	$3M	$2M	$7M	·
Total Liabilities	$359M	$337M	$399M	$426M	$416M	$199M	$192M	$195M	$199M	$117M	·	$93M	$119M	$146M	$35M	·
Common Stock	$2.14B	$2.13B	$1.93B	$1.74B	$1.74B	$1.69B	$1.66B	$1.38B	$1.30B	$911M	·	$619M	$618M	$616M	·	·
Paid-in Capital	$220M	$203M	$194M	$178M	$157M	$137M	$112M	$93M	$84M	$69M	·	$26M	$22M	$17M	·	·
Retained Earnings	$-2.35B	$-2.22B	$-2.08B	$-1.94B	$-1.77B	$-1.57B	$-1.35B	$-1.16B	$-999M	$-679M	·	$-355M	$-252M	$-162M	·	·
AOCI	$5M	$8M	$8M	$36.0K	$-3.0K	$73.0K	$79.0K	$140.0K	$-78.0K	$-106.0K	·	$158.0K	$20.0K	$166.0K	·	·
Stockholders' Equity	$12M	$130M	$52M	$-17M	$135M	$259M	$423M	$316M	$384M	$301M	$428M	$290M	$387M	$472M	$100M	·
Liabilities + Equity	$371M	$466M	$451M	$409M	$550M	$459M	$615M	$511M	$583M	$419M	·	$383M	$507M	$619M	$136M	·
Shares Outstanding	151,017,531	150,506,490	132,775,113	105,803,655	105,782,447	102,104,024	101,221,989	94,899,193	92,346,332	81,807,221	·	68,364,143	68,316,953	68,212,479	100	·

Nakit Akışı 11

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
D&A	$2M	$2M	$3M	$3M	$2M	$2M	$2M	$2M	$2M	$1M	$2M	$2M	$2M	$2M	$377.0K	$415.0K
Stock-based Comp	$19M	$28M	$17M	$22M	$21M	$53M	$13M	$12M	$12M	$35M	$16M	$4M	$5M	$4M	$17M	$21M
Other Non-cash	·	$-50M	·	·	·	$1M	·	·	·	$41M	·	·	·	$-13M	·	·
Operating Cash Flow	$-85M	$-150M	$-131M	$-146M	$-168M	$-165M	$-171M	$-141M	$-168M	$-103M	$-115M	$-95M	$-44M	$-78M	$-96M	$-68M
CapEx	$454.0K	$0	$8.0K	$13.0K	$233.0K	$461.0K	$49.0K	$611.0K	$3M	$440.0K	$470.0K	$1M	$595.0K	$735.0K	$5M	$1M
Investing Cash Flow	$45M	$15M	$-14M	$165M	$-16M	$165M	$-88M	$-93M	$-98M	$34M	$-4M	$59M	$76M	$-1M	$-5M	$-36M
Stock Issued	$0	$179M	$189M	$0	$0	$0	$271M	$76M	·	·	$243M	$0	·	·	·	·
Net Stock Activity	·	$179M	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Financing Cash Flow	$4M	$179M	$189M	$122.0K	$250M	$369.0K	$273M	$80M	$321M	$3M	$245M	$-40M	$-20M	$27M	$128M	$87M
Net Change in Cash	$-36M	$44M	$44M	$19M	$66M	$147.0K	$15M	$-154M	$55M	$-65M	$126M	$-76M	$11M	$-52M	$27M	$-17M
Free Cash Flow	·	$-150M	·	·	·	$-166M	·	·	·	$-103M	·	·	·	$-78M	·	·

Kârlılık 3

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
ROA	-29.8%	-28.2%	·	-37.7%	-35.0%	-50.5%	·	-35.9%	-58.7%	-34.6%	·	-39.6%	-35.7%	-22.8%	-101.5%	·
ROE	-187.1%	-67.1%	·	-116.1%	-76.5%	-79.0%	·	-52.9%	-83.0%	-46.4%	·	-52.6%	-46.7%	-29.8%	-137.4%	·
ROIC	-1024.8%	-100.9%	·	988.3%	-157.5%	-85.6%	·	-56.4%	-87.0%	-61.0%	·	-36.9%	-24.9%	-16.7%	-68.7%	·

Likidite ve Solventlik 2

Metrik	Eğilim	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Current Ratio		4.7	7.4	·	2.9	3.8	2.3	·	2.9	3.3	4.0	·	5.0	4.9	4.8	2.8	·
Quick Ratio		4.3	6.7	·	2.3	3.3	2.0	·	2.5	2.8	3.3	·	3.9	3.8	3.4	1.8	·

Hisse Başına 4

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Book Value / Share	$0.08	$0.86	·	$-0.16	$1.27	$2.54	·	$3.33	$4.16	$3.68	·	$4.24	$5.67	$6.92	$1002160.00	·
Cash Flow / Share	·	$-1.02	·	·	·	$-1.62	·	·	·	$-1.26	·	·	·	$-1.14	·	·
Cash / Share	$1.58	$1.81	·	$1.75	$1.57	$0.96	·	$0.89	$2.59	$2.23	·	$1.63	$2.16	$1.83	$506680.00	·
EPS (TTM)	$-4.54	$-5.57	·	$-7.49	$-7.55	$-9.25	·	$-9.42	$-9.22	$-6.90	·	$-7.23	$-7.48	$-11.32	$-10.69	$-10.32

Değerleme (TTM) 7

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Net Income TTM	$-587M	$-648M	·	$-780M	$-767M	$-889M	·	$-804M	$-747M	$-517M	·	$-465M	$-431M	$-544M	$-421M	$-407M
Market Cap	$2.25B	$1.27B	·	$1.59B	$1.49B	$2.45B	·	$4.74B	$3.21B	$4.47B	·	$1.78B	$1.63B	$932M	$616	·
P/E	-3.3	-1.5	·	-2.0	-1.9	-2.6	·	-5.3	-3.8	-7.9	·	-3.6	-3.2	-1.2	-0.6	·
P/B	183.9	9.8	·	-92.5	11.1	9.5	·	15.0	8.4	14.8	·	6.1	4.2	2.0	0.0	·
P / Tangible Book	·	11.6	·	·	13.0	10.2	·	16.0	8.8	15.9	·	6.6	4.4	2.1	0.0	·
P / Cash Flow	·	-8.5	·	·	·	-14.9	·	·	·	-43.6	·	·	·	-12.0	·	·
Earnings Yield	-30.5%	-65.8%	·	-49.9%	-53.5%	-38.5%	·	-18.9%	-26.6%	-12.6%	·	-27.8%	-31.3%	-82.9%	-173.6%	·

En son dönem solda · null değerler · olarak gösterilir

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

16

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Net Gelir	$-739M	$-846M	$-408M	$-570M	$-214M
Seyreltilmiş Hisse Başı Kâr	$-6.86	$-9.28	$-5.73	$-12.75	$-5.43

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Cari Oran	3.2	3.5	8.0	6.5	·
Cari Oran	2.8	3.2	6.9	5.2	·

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Serbest Nakit Akışı	$-610M	$-587M	$-335M	$-304M	·

Kurumsal Sahipler (13F) 326 dosya · $2.3B toplam · Tarih itibarıyla 30 Eylül 2026

17

Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.

Sahipler 326

Tutulan Değer $2.3B

Yeni pozisyonlar 55

Çıkan pozisyonlar 31

Kurumsal faaliyet — Q2 2026 ve önceki çeyrek

Yeni pozisyonlar	Çıkan pozisyonlar	Artırıldı	Azaldı	Net hisse senedi değişimi
55 (+3 önceki Ç'ye göre)	31 (-6 önceki Ç'ye göre)	110 (-5 önceki Ç'ye göre)	84 (+14 önceki Ç'ye göre)	-8.9M

Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.

Kurum	Değer	Hisse senetleri	% izlenen 13F'nin	Tür
BlackRock, Inc.	$196.573.505	13.210.585	8,61%	Hisse senetleri
MONTANOVA CAPITAL, LLC	$153.069.623	10.286.937	6,71%	Hisse senetleri
JANUS HENDERSON GROUP PLC	$148.213.808	17.534.612	6,50%	Hisse senetleri
STIFEL FINANCIAL CORP	$147.924.530	9.941.165	6,48%	Hisse senetleri
Woodline Partners LP	$113.984.966	7.660.280	5,00%	Hisse senetleri
STATE STREET CORP	$103.371.866	6.947.034	4,53%	Hisse senetleri
INFINITUM ASSET MANAGEMENT, LLC	$93.000.000	6.250.000	4,08%	Hisse senetleri
RP Management, LLC	$70.593.628	2.936.507	3,09%	Hisse senetleri
D. E. Shaw & Co., Inc.	$62.350.102	4.190.195	2,73%	Hisse senetleri
AQR CAPITAL MANAGEMENT LLC	$61.761.159	4.150.616	2,71%	Hisse senetleri
VANGUARD GROUP INC	$49.630.230	4.395.946	2,18%	Hisse senetleri
GEODE CAPITAL MANAGEMENT, LLC	$49.460.273	3.323.190	2,17%	Hisse senetleri
FMR LLC	$44.113.698	2.964.630	1,93%	Hisse senetleri
Royalty Pharma Sub-Manager, LLC	$43.695.224	2.936.507	1,91%	Hisse senetleri
Cormorant Asset Management, LP	$38.836.800	2.610.000	1,70%	Hisse senetleri
GOLDMAN SACHS GROUP INC	$38.435.724	2.583.046	1,68%	Hisse senetleri
UBS Group AG	$37.480.146	2.518.827	1,64%	Hisse senetleri
VANGUARD PORTFOLIO MANAGEMENT LLC	$37.035.442	2.488.941	1,62%	Hisse senetleri
Balyasny Asset Management L.P.	$27.970.442	1.879.734	1,23%	Hisse senetleri
TCG Crossover Management, LLC	$26.485.686	1.779.952	1,16%	Hisse senetleri
Nuveen, LLC	$25.955.690	1.744.334	1,14%	Hisse senetleri
Rubric Capital Management LP	$25.615.816	1.721.493	1,12%	Hisse senetleri
CITADEL ADVISORS LLC	$24.100.779	1.619.676	1,06%	Hisse senetleri
VANGUARD CAPITAL MANAGEMENT LLC	$22.153.478	1.488.809	0,97%	Hisse senetleri
BANK OF AMERICA CORP /DE/	$21.990.229	1.477.838	0,96%	Hisse senetleri
ARS Investment Partners, LLC	$20.447.873	1.374.185	0,90%	Hisse senetleri
BNP PARIBAS FINANCIAL MARKETS	$18.219.399	1.224.422	0,80%	Hisse senetleri
Capital Research Global Investors	$17.849.230	1.199.545	0,78%	Hisse senetleri
NORTHERN TRUST CORP	$17.650.820	1.186.211	0,77%	Hisse senetleri
MYDA Advisors LLC	$17.112.000	1.150.000	0,75%	Hisse senetleri
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$16.506.131	1.109.283	0,72%	Hisse senetleri
STEMPOINT CAPITAL LP	$15.835.296	1.064.200	0,69%	Hisse senetleri
Simplify Asset Management Inc.	$15.478.994	1.040.255	0,68%	Hisse senetleri
ADAGE CAPITAL PARTNERS GP, L.L.C.	$14.880.000	1.000.000	0,65%	Hisse senetleri
Qube Research & Technologies Ltd	$13.480.313	905.935	0,59%	Hisse senetleri
VOLORIDGE INVESTMENT MANAGEMENT, LLC	$13.134.933	882.724	0,58%	Hisse senetleri
MORGAN STANLEY	$12.519.320	841.351	0,55%	Hisse senetleri
VANGUARD FIDUCIARY TRUST CO	$12.332.232	828.779	0,54%	Hisse senetleri
Ikarian Capital, LLC	$11.132.933	748.181	0,49%	Hisse senetleri
Erste Asset Management GmbH	$11.022.635	737.300	0,48%	Hisse senetleri
5AM Venture Management, LLC	$10.995.903	738.972	0,48%	Hisse senetleri
Iron Triangle Partners LP	$10.819.613	958.336	0,47%	Hisse senetleri
Integral Health Asset Management, LLC	$10.416.000	700.000	0,46%	Hisse senetleri
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$9.780.624	657.300	0,43%	Alım opsiyonu
MARSHALL WACE, LLP	$9.692.074	651.349	0,42%	Hisse senetleri
Longaeva Partners L.P.	$8.926.557	599.903	0,39%	Hisse senetleri
ORACLE INVESTMENT MANAGEMENT INC	$8.717.923	772.181	0,38%	Hisse senetleri
Sarissa Capital Management LP	$8.664.803	582.312	0,38%	Hisse senetleri
Pfizer Inc	$8.004.360	505.645	0,35%	Hisse senetleri
Eversept Partners, LP	$7.675.164	515.804	0,34%	Hisse senetleri

Tüm 326 kurumsal sahibi göster →

Şirket yöneticileri 13 içeriden öğrenenler · 5 yöneticiler · 5 yönetim kurulu üyeleri

19

İçeriden Öğrenen	Rol	Son işlem	Sahip olunan hisse senetleri	Alımlar 12ay	Net 12ay
Vlad Coric	Chief Executive Officer	27 Şubat 2026 A	1.803.968	2	$4.999.996
Matthew Buten	Chief Financial Officer	27 Şubat 2026 A	195.652	0	$0
Kimberly Gentile	SVP, Clinical Operations	15 Eylül 2026 A	99.557	0	$0
George C. Clark	VP, Chief Accounting Officer	27 Şubat 2026 A	66.978	1	$144.840
Bruce Car	Chief Scientific Officer	27 Şubat 2026 A	7.715	0	$0
Irina Antonijevic	Yönetim kurulu üyesi	28 Nisan 2026 A	2.535	0	$0
Kishan Mehta	Yönetim kurulu üyesi	28 Nisan 2026 A	17.342	0	$0
Michael Thomas Heffernan	Yönetim kurulu üyesi	28 Nisan 2026 A	15.178	0	$0
John W Childs	Yönetim kurulu üyesi	28 Nisan 2026 A	2.323.971	2	$25.864.210
Biohaven Pharmaceutical Holding Co Ltd.	10% sahip	03 Ekim 2022 J	0	0	$0
Gregory H. Bailey	·	28 Nisan 2026 A	2.020.071	1	$3.000.000
Robert J Hugin	·	28 Nisan 2026 A	12.959	0	$0
Julia P Gregory	·	28 Nisan 2026 A	25.665	0	$0

SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış

ETF sahipliği 19 ETF'ler tarafından tutuluyor

20

Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.

Fon	Ağırlık	Birimler	Tarih itibarıyla	Kaynak
IBRN · iShares Trust	1,68%	9.836 SH	11 Eylül 2026	Günlük
LABU · Direxion Shares ETF Trust	0,35%	128.814 NS	31 Temmuz 2026	N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust	0,13%	255.530 SH	02 Ekim 2026	Günlük
NUSC · Nushares ETF Trust	0,13%	120.245 NS	31 Temmuz 2026	N-PORT
VTWG · VANGUARD SCOTTSDALE FUNDS	0,12%	143.177 SH	19 Ağustos 2026	Günlük
IBB · iShares Trust	0,12%	957.494 SH	11 Eylül 2026	Günlük
IWO · iShares Trust	0,11%	1.252.927 SH	11 Eylül 2026	Günlük
ESML · iShares Trust	0,07%	161.187 SH	11 Eylül 2026	Günlük
VTWO · VANGUARD SCOTTSDALE FUNDS	0,06%	768.380 SH	19 Ağustos 2026	Günlük
RSSL · Global X Funds	0,06%	63.802 NS	31 Temmuz 2026	N-PORT
IWM · iShares Trust	0,06%	3.410.283 SH	11 Eylül 2026	Günlük
VHT · VANGUARD WORLD FUND	0,03%	373.567 SH	19 Ağustos 2026	Günlük
VXF · VANGUARD INDEX FUNDS	0,02%	1.488.809 SH	19 Ağustos 2026	Günlük
WSML · iShares Trust	0,01%	7.762 SH	11 Eylül 2026	Günlük
IWV · iShares Trust	0,00%	36.959 SH	11 Eylül 2026	Günlük
ITOT · iShares Trust	0,00%	169.731 SH	11 Eylül 2026	Günlük
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	11.060 SH	19 Ağustos 2026	Günlük
ISCB · iShares Trust	·	5.941 SH	11 Eylül 2026	Günlük
ISCV · iShares Trust	·	28.693 SH	11 Eylül 2026	Günlük

BHVN Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

21

derecelendirme · 23 analist AL

Medyan hedef $20.00 +56,0%

7 30,4% Güçlü Al

11 47,8% Al

4 17,4% Tut

1 4,3% Sat

0 0,0% Güçlü Sat

12 Aylık Fiyat Hedefi

15 analist · 2026-10-01

Ortalama hedef $21.27 +65,9%

Şimdi Mevcut fiyat $12.82

Düşük$10.00 Ortalama$21.27 Yüksek$42.00

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

22

Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.

Hisse Sembolü	Piyasa Değeri	P/E	Gelir YoY	Net Kar Marjı	ROE	Brüt Kar Marjı
BHVN	$1.50B	-1.6	·	·	-310.8%	·
VERA	·	-10.9	·	·	-55.9%	·
MLYS	$2.96B	-15.8	·	·	-32.2%	·
BCRX	$1.66B	6.4	94.1%	30.2%	-97.6%	·
VCEL	$1.82B	112.5	16.4%	6.0%	5.0%	74.4%
ZBIO	$1.98B	-4.3	100.0%	-3777.4%	-156.8%	·
PVLA	$1.30B	-28.2	65.3%	-1610.6%	-110.1%	·
ABSI	$529M	-4.2	-38.2%	-4113.7%	-63.5%	·
AGIO	$1.59B	-3.8	48.0%	-764.0%	-32.2%	·
VIR	$841M	-1.9	-7.6%	-638.9%	-51.1%	·
SRPT	$2.26B	-3.0	15.6%	-32.5%	-57.1%	·

Son Haberler Bu şirketten bahseden son manşetler

23

Neden Biohaven Hissesi Pazartesi Günü Yıkıldı Nasdaq · 5 ay, 3 hafta önce

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

26

Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

BHVN Biohaven Ltd. Common Shares